市场调查报告书
商品编码
1425147
高流量针组市场 – 2024 年至 2029 年预测High Flow Needle Sets Market - Forecasts from 2024 to 2029 |
2022 年,高流量针套市值为 7.8965 亿美元,预计在预测期内复合年增长率为 5.64%。
高流量针头组是专为确保使用者安全和舒适而设计的针头组。这种类型的针用于将更黏稠的药物注射到体内。高流量针头组比标准针头更舒适快速。慢性病的增加和医疗保健技术的进步是支持高流量针组市场显着成长的关键驱动力。
市场驱动因素
慢性病的流行是高流量针组市场的关键驱动因素。癌症、心血管疾病和出血性疾病的发生率正在上升,这些疾病通常需要频繁的药物和输液,因此需要使用高流量针头套件。例如,根据世界卫生组织(WHO)统计,非传染性疾病每年导致4100万人死亡,占全球总死亡人数的74%,其中77%因非传染性疾病死亡。- 收入国家。
医疗保健技术的进步在提高安全性、准确性和相容性的高流量针头套件的开发中发挥了关键作用。这为高流量针头套件的开发铺平了道路,以提高患者的舒适度和安全性。由于製造商持续关注技术创新,市场显着成长。例如,2023年1月,科尔医疗系统公司与一家製药公司提案了一项皮下免疫球蛋白疗法(SCIg)的开发协议,寻求建立并核准带有SCIg预充式预填充式注射器的Freedom Infusion System。这有利于患者在家中的药物输送。
技术进步在扩大高流量注射器针头组市场方面发挥重要作用。许多国家正在投资加强其医疗基础设施,导致对高流量针头等先进医疗设备的需求增加。此外,慢性病发病率较高的人口不断增长,以及对高流量针组益处的认识不断提高,也推动了这种扩张。例如,2021 年 10 月,印度政府启动了 Pradhan Mantri Ayushman Bharat 卫生基础设施任务。该计画宣布,截至 25-26 财年预计支出为 6,418 亿卢比。这是该国最大的泛印度计划,旨在改善医疗基础设施,也增加了对高低针组等医疗设备的需求。
预计北美将主导市场
由于该地区主要国家的高医疗保健标准和各种慢性病的盛行率不断上升,预计北美将占据重要的市场占有率。美国政府正在投资医疗基础设施和医疗产品,显着增加了对高流量针组的需求。例如,国家医疗支出帐户追踪美国每年在医疗保健商品和服务、政府营运和医疗保健投资方面的支出。 2021年,美国医疗保健支出将成长2.7%,达到4.3兆美元,即人均12,914美元。医疗卫生支出占国内生产总值的18.3%。
市场挑战
高流量针组市场的成长可能会受到针刺伤害和医疗中心医护人员的安全疑虑的限制。针刺伤危及在医疗过程中使用高流量针组的医护人员的生命。这些损伤会传播血液传播的病原体,例如爱滋病毒、B型肝炎和C型肝炎。医护人员的健康和福祉对于医疗保健系统的整体运作至关重要。
公司产品
The high-flow needle sets market was valued at US$789.65 million in 2022 and is expected to grow at a CAGR of 5.64% during the forecast period.
High-flow needle sets are needle sets that are created to ensure user safety and comfort. While administering more viscous drugs to the body, these types of needles are used. High-flow needle sets are more comfortable and faster than standard needles. Growing chronic disease prevalence, and healthcare technology advancement have emerged as a significant driving force behind the substantial growth of the high-flow needle sets market.
Market Drivers
Chronic disease prevalence is a significant driver of the high-flow needle set market. Cancer, cardiovascular disease, and bleeding disorders are on the rise, and these conditions usually require frequent medication or fluid withdrawal, which requires the use of high-flow needle sets. For instance, according to the World Health Organization, non-communicable diseases kill 41 million people per year, accounting for 74% of the total deaths worldwide, and 77% of non-communicable disease deaths occur in low- and middle-income countries.
Advances in healthcare technology have played a vital role in the development of high-flow needle sets with improved safety, preciseness, and compatibility. It established the way for the development of high-flow needle sets that support patient comfort and security. The market has grown significantly fueled by the manufacturer's ongoing focus on innovation. For instance, in January 2023, KORU Medical Systems proposed a development agreement with the pharmaceutical company of subcutaneous immunoglobulin therapy (SCIg) to establish and seek approval for a Freedom Infusion System with a SCIg prefilled syringe. This will make the subcutaneous delivery of drugs easier for patients at home.
Technology advancements play a vital role in high-flow needle sets market expansion. Many countries are making investments to enhance their healthcare infrastructure, which led to an increase in demand for advanced medical equipment such as high-flow needle sets. This expansion is fueled additionally by the growing population, which is more likely to suffer from chronic diseases, as well as increased awareness of the benefits of high-flow needle sets. For instance, in October 2021, the Government of India launched the Pradhan Mantri Ayushman Bharat Health Infrastructure Mission. This scheme was announced with an estimated outlay of Rs. 64,180 Cr until FY 25-26. It is the country's largest pan-India scheme for improving healthcare infrastructure as well as the increase in demand for medical equipment such as high-low needle sets.
North America is anticipated to dominate the market
North America will account for a considerable market share owing to the high medical standards and increased prevalence of various chronic diseases in the region's major economies. The U.S. government is investing in healthcare infrastructures and healthcare goods which substantially increases the demand for high-flow needle sets. For instance, National Health Expenditure Accounts tracks annual U.S. spending on healthcare goods and services, government operations, and health-care investment. In 2021, healthcare spending in the United States will increase by 2.7 percent to $4.3 trillion, or $12,914 per person. Health spending accounted for 18.3 percent of the nation's Gross Domestic Product.
Market Challenges
The growth of the high-flow needle sets market may be restrained by needlestick injuries and safety concerns for healthcare workers in medical centers. Needlestick injuries endanger the lives of healthcare workers who use high-flow needle sets during medical procedures. These injuries have a chance to spread bloodborne pathogens such as HIV, hepatitis B, and hepatitis C. The health and well-being of healthcare workers are critical to the overall operation of healthcare systems.
Market Development
Company Products
Segmentation